 Alliancebernstein L.P. reduced its holdings in shares of Amicus Therapeutics, Inc. NASDAQ:FOLD by 32.6 during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 358,036 shares of the biopharmaceutical companys stock after selling 173,467 shares during the period. Alliancebernstein L.P. owned approximately 0.14 of Amicus Therapeutics worth 3,308,000 ... 